ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1111

$646K Total Retail Price of All Prescriptions

Rank: 125 out of 1111

324 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 9,461 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
POTASSIUM CHLORIDE 394 375 1 9
LEVOTHYROXINE SODIUM 387 358 2 3
FUROSEMIDE 361 322 3 6
LISINOPRIL 357 325 4 2
METOPROLOL TARTRATE 313 288 5 12
HYDROCODONE-ACETAMINOPHEN 291 214 S3 6 1
AMLODIPINE BESYLATE 285 260 7 7
METFORMIN HCL 275 230 8 8
SIMVASTATIN 249 208 9 5
POLYETHYLENE GLYCOL 3350 233 184 10 45
OMEPRAZOLE 232 207 11 4
HYDROCHLOROTHIAZIDE 214 188 12 11
GABAPENTIN 200 148 13 10
NAMENDA 177 159 14 31
DONEPEZIL HCL 173 155 15 25
MIRTAZAPINE 169 136 16 52
CIPROFLOXACIN HCL 140 119 17 58
CITALOPRAM HBR 130 129 18 14
SERTRALINE HCL 123 110 19 24
METOPROLOL SUCCINATE 122 115 20 20
RANITIDINE HCL 116 90 21 29
ALENDRONATE SODIUM 115 115 22 35
ATORVASTATIN CALCIUM 107 104 23 15
FENTANYL 107 62 S2 23 65
ZOLPIDEM TARTRATE 99 73 25 16
QUETIAPINE FUMARATE 99 96 25 76
TAMSULOSIN HCL 98 82 27 28
WARFARIN SODIUM 95 93 28 19
MUPIROCIN 92 58 29 154
ADVAIR DISKUS 88 57 30 43
ROPINIROLE HCL 88 82 30 68
LANTUS 87 76 32 46
MELOXICAM 86 53 33 18
TERAZOSIN HCL 84 77 34 127
GLYBURIDE 84 83 R 34 59
CYMBALTA 80 52 36 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 69 37 23
CARVEDILOL 77 74 38 21
OXYBUTYNIN CHLORIDE ER 73 37 39 114
METOLAZONE 71 67 40 162
CLOPIDOGREL 70 59 41 30
DIVALPROEX SODIUM 70 57 41 82
DETROL LA 67 58 43 139
PLAVIX 67 56 43 49
PANTOPRAZOLE SODIUM 65 43 45 50
NOVOLIN R 64 40 46 142
NEXIUM 64 45 46 26
EVISTA 61 60 48 148
CELEBREX 59 52 49 81
FLUTICASONE PROPIONATE 59 36 49 27
PRAVASTATIN SODIUM 58 44 51 17
ISOSORBIDE MONONITRATE ER 55 55 52 73
TRAZODONE HCL 54 43 53 32
RISPERIDONE 53 53 54 60
SEROQUEL 52 52 55 170
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 55 72
SPIRONOLACTONE 52 51 55 83
ALLOPURINOL 51 36 58 36
METFORMIN HCL ER 50 50 59 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.